BEGIN:VCALENDAR
VERSION:2.0
PRODID: -//Q4 Inc.//EN
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
ORGANIZER:MAILTO:investors@fortebiorx.com
DTSTART;TZID="America/New_York":20250915T090000
DTEND;TZID="America/New_York":20250915T090000
LOCATION:
UID:38c9933b-96ba-45e8-a7f7-c49f806d552a
DTSTAMP:20260828T095301
SUMMARY:Tampere Celiac Disease Symposium 2025 FB102 Phase 1b Oral Presentation
DESCRIPTION: View More Information: https://www.fortebiorx.com/investor-relations/events-and-presentations/event-calendar/event-details/2025/FB102-prevents-histological-damage-and-mitigates-gluten-challenge-induced-symptoms-in-a-celiac-disease-Phase-1b-study/default.aspx
URL;VALUE=URI:https://www.fortebiorx.com/investor-relations/events-and-presentations/event-calendar/event-details/2025/FB102-prevents-histological-damage-and-mitigates-gluten-challenge-induced-symptoms-in-a-celiac-disease-Phase-1b-study/default.aspx
PRIORITY:5
CLASS:PUBLIC
END:VEVENT
END:VCALENDAR